{
    "startDate": "2017-01-01",
    "endDate": "2017-06-30",
    "year": "2017",
    "quarter": "Q2",
    "symbol": "THLD",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 16468000
            },
            {
                "label": "Marketable securities, current",
                "concept": "AvailableForSaleSecuritiesCurrent",
                "unit": "usd",
                "value": 300000
            },
            {
                "label": "Notes receivable current.",
                "concept": "thld:NotesReceivableCurrent",
                "unit": "usd",
                "value": 4000000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 93000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 20861000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "ASSETS",
                "concept": "Assets",
                "unit": "usd",
                "value": 20861000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 319000
            },
            {
                "label": "Payable to Merck KGaA for Threshold's share of collaboration expenses.",
                "concept": "thld:CollaborationPayable",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accruals for clinical trial and development expenses.",
                "concept": "thld:AccruedClinicalAndDevelopmentLiabilities",
                "unit": "usd",
                "value": 246000
            },
            {
                "label": "Accrued liabilities",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 1915000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 2480000
            },
            {
                "label": "Warrant liability",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1494000
            },
            {
                "label": "Deferred rent",
                "concept": "DeferredRentCreditNoncurrent",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 3974000
            },
            {
                "label": "Commitments and contingencies (Note 7)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Preferred stock, $0.001 par value, 2,000,000 shares authorized; no shares issued and outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $0.001 par value, shares authorized: 150,000,000 shares; issued and outstanding: 71,591,918 shares at June 30, 2017 and 71,560,294 shares at December 31, 2016",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 72000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 374278000
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 0
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -357463000
            },
            {
                "label": "Stockholders\u2019 equity:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 16887000
            },
            {
                "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 20861000
            }
        ],
        "cf": [
            {
                "label": "Net income (loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -3929000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationAndAmortization",
                "unit": "usd",
                "value": 25000
            },
            {
                "label": "Gain on sale of property and equipment",
                "concept": "GainLossOnDispositionOfAssets1",
                "unit": "usd",
                "value": 21000
            },
            {
                "label": "Stock-based compensation expense",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 919000
            },
            {
                "label": "Change in common stock warrant fair value",
                "concept": "GainLossOnDerivativeInstrumentsNetPretax",
                "unit": "usd",
                "value": 249000
            },
            {
                "label": "Increase (decrease) in receivables or payables from collaboration partners.",
                "concept": "thld:IncreaseDecreaseInReceivablesOrPayablesFromCollaborationPartners",
                "unit": "usd",
                "value": 129000
            },
            {
                "label": "Prepaid expenses and other assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -530000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": -503000
            },
            {
                "label": "Increase decrease in accrued clinical and development liabilities.",
                "concept": "thld:IncreaseDecreaseInAccruedClinicalAndDevelopmentLiabilities",
                "unit": "usd",
                "value": -531000
            },
            {
                "label": "Accrued liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilities",
                "unit": "usd",
                "value": 1027000
            },
            {
                "label": "Deferred rent",
                "concept": "IncreaseDecreaseInDeferredCharges",
                "unit": "usd",
                "value": 36000
            },
            {
                "label": "Cash flows from operating activities:",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -2897000
            },
            {
                "label": "Issuance of short-term promissory note to Molecular Templates, Inc.",
                "concept": "thld:IssuanceOfPromissoryNoteToMolecularTemplates",
                "unit": "usd",
                "value": 4000000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireAvailableForSaleSecurities",
                "unit": "usd",
                "value": 299000
            },
            {
                "label": "Proceeds from sale of property and equipment",
                "concept": "ProceedsFromSaleOfPropertyPlantAndEquipment",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Proceeds from maturities of marketable securities",
                "concept": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
                "unit": "usd",
                "value": 13006000
            },
            {
                "label": "Cash flows from investing activities:",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 8807000
            },
            {
                "label": "Proceeds from issuance of common stock and warrants",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 7000
            },
            {
                "label": "Cash flows from financing activities:",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 7000
            },
            {
                "label": "Net increase in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": 5917000
            }
        ],
        "ic": [
            {
                "label": "Revenue",
                "concept": "ContractsRevenue",
                "unit": "usd",
                "value": 3000000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 2705000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 4540000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 7245000
            },
            {
                "label": "Income (loss) from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -4245000
            },
            {
                "label": "Interest income (expense), net",
                "concept": "InterestIncomeExpenseNonoperatingNet",
                "unit": "usd",
                "value": 67000
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 249000
            },
            {
                "label": "Net income (loss)",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -3929000
            },
            {
                "label": "Unrealized gain (loss) on available-for-sale securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -2000
            },
            {
                "label": "Comprehensive income (loss)",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -3931000
            },
            {
                "label": "Basic",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.05
            },
            {
                "label": "Diluted",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": -0.05
            },
            {
                "label": "Basic",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 71584000
            },
            {
                "label": "Diluted",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": 71584000
            }
        ]
    }
}